Thirty-two patients with port-wine stain were included in this study. The 585 nm
pulsed dye laser treatment with an air cooling device was repeated 4 times at 8 – week
intervals with a setting of 0.5 ms pulse duration and an average energy fluence
5 - 6.5 J/
cm2, using 7 mm spot size.
The results revealed improvement of port-wine stains after multiple treatments , and
69% of the patients achieved good or excellent clearance after the fourth treatment.
Transient purpura and tolerable pain were noted immediately after each treatment (87.5%),
crusting (25%), hypopigmentation (9%), hyperpigmentation (6%) were also mild and their
occurrence didn’t increase by repeating treatment.
The results of this study indicated that the 585 nm PDL is effective and well tolerated
in the treatment of port wine stain.
Objective: Febrile seizures are the most common seizures in children less than 5
years(2-5%),and the risk of its recurrence is 50%(>1year),30%(<1year).We focused on the
effect and safety of the prophylaxis treatment of recurrent FS beacuase it is a
terrifying
case for the parents.
Materials&Methods:This is a trial study on 40 patient with FS.Clonazepam was
recommended 0.05mg/kg/d then anti e when fever exceed 38°.We did follow up every 3
month during one year.
Results:we followed 35 patient, familial history of FS found in 57.1%,a history of
epilepsy in 28.57%.clonazepam side effects were supportable the most common was
lawson 14.28%,the efficacy of the treatment we didn’t noticed any episode of FS during
the study 97.1%.
Conclusion: Clonazepam is a safe and effective and easy treatement for the parents
for the prophylaxis of FS recurrence.
The toxic effect of some insecticides (Amitraz, Amitraz + summer oil,
Abamectin, Abamectin + summer oil) and plant extracts (Melia azedarach L.,
M. azedarach + summer oil, Schinus molle L., S. molle + summer oil) were
tested on the predator of pea
r psyllae insect Anthocoris nemoralis F. and the
parasite Trechnites psyllae R. in the Mokhtaria research station, agricultural
research center at Homs during the season 2011.
This paper presents a new solution that allows the doctors to know drug interactions,
considering other affecting factors such as the patient's age, weight, physiological and
pathological condition. This solution is characterized by being increment
al, not only by
enriching the database with drug interactions information, but also by its ability to conclude
other interactions through a built-in expert system. The system concludes drugs interactions
based on its active substrates and the potential interactions between them or between the drugs
families. The system serves in three ways; it determines whether the patient illness is possibly
due to the medications he is on. It alerts the doctor to the interaction of the newly prescribed
medication with the patient’s medications, and to its influence on the patient’s physiological or
pathological condition. Besides, it suggests alternative drugs when needed. The solution offers
additional services such as binding between the brand name and the generic drug, and between
drugs and diseases.
النظم الخبيرة
التداخلات الدوائية
الحالة الفيزيولوجية
الحالة المرضية
الآثار الجانبية
العائلة الدوائية
المادة الفعالة
الاسم العلمي
الاسم التجاري
الاستطبابات
Expert Systems
Drugs Interactions
Active Substrate
Medical Group
Genuine Name
Trade Name
physiological condition
pathological condition
Side Effects
Indications
المزيد..